Tizanidine

Product NDC
50090-2208
11-digit product format
500902208
Labeler code
50090
Product ID
50090-2208_d1bca1da-883d-4e50-a331-26510a9a11f6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tizanidine
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA076416
Marketing category
ANDA
Marketing start
2003-12-11
Marketing end
0000-00-00
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a0ff02d8-b711-423c-b7d1-ada00d81c743Product name120250805
9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01Product name820250313
b404127e-1c01-47bb-874e-db1e0b6bd9afProduct name420250313

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50090-2208-02023-01-30C16284748780-1f386c649-b421-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
50090-2208-22023-01-30C16284748780-1f386c649-b421-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
50090-2208-32023-01-30C16284748780-1f386c649-b421-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
50090-2208-42023-01-30C16284748780-1f386c649-b421-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
50090-2208-62023-01-30C16284748780-1f386c649-b421-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
50090-2208-72023-01-30C16284748780-1f386c649-b421-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-2208-0Tizanidine120 in 1 BOTTLETABLET12016
50090-2208-2Tizanidine60 in 1 BOTTLETABLET6016
50090-2208-3Tizanidine15 in 1 BOTTLETABLET1516
50090-2208-4Tizanidine30 in 1 BOTTLETABLET3016
50090-2208-6Tizanidine90 in 1 BOTTLETABLET9016
50090-2208-7Tizanidine14 in 1 BOTTLETABLET1416

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-2208TIZANIDINE TABLET [A-S MEDICATION SOLUTIONS]16Legacy NDC, 6 package rows20210303_cf0dca9d-37ff-4c21-a5cc-56d4839d4d35.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313413tiZANidine HCl 4 MG Oral TabletPSNcf0dca9d-37ff-4c21-a5cc-56d4839d4d3516
313413tizanidine 4 MG Oral TabletSCDcf0dca9d-37ff-4c21-a5cc-56d4839d4d3516
313413tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral TabletSYcf0dca9d-37ff-4c21-a5cc-56d4839d4d3516

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-2208-050090220800120 TABLET in 1 BOTTLE (50090-2208-0) 120 tablet2015-11-020000-00-00NoNoCurrent
50090-2208-25009022080260 TABLET in 1 BOTTLE (50090-2208-2) 60 tablet2015-11-020000-00-00NoNoCurrent
50090-2208-35009022080315 in 1 BOTTLEHistorical
50090-2208-45009022080430 TABLET in 1 BOTTLE (50090-2208-4) 30 tablet2015-11-020000-00-00NoNoCurrent
50090-2208-65009022080690 TABLET in 1 BOTTLE (50090-2208-6) 90 tablet2015-11-020000-00-00NoNoCurrent
50090-2208-75009022080714 TABLET in 1 BOTTLE (50090-2208-7) 14 tablet2015-11-020000-00-00NoNoCurrent